Physician profile
Nelson Menezes
NPI 1255425948
$832.99
in general payments reported to CMS, 2019-2025
12 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $67.56 · 2022: $91.17 · 2023: $90.33 · 2024: $86.87 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $148.76 | 2019-2022 | |
| Medtronic Vascular, INC. | $135.53 | 2019 | |
| Advanced Oxygen Therapy INC. | $129.63 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $122.52 | 2020-2025 | Collagenase Santyl |
| Boston Scientific Corporation | $120.82 | 2019-2022 | |
| Davol INC. | $38.38 | 2025 | Phasix Mesh |
| Terumo Medical Corporation | $33.44 | 2020 | |
| Inari Medical, INC. | $31.98 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Aroa Biosurgery Incorporated | $23.66 | 2025 | |
| Abbvie INC. | $23.52 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Menezes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.